These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21308251)

  • 1. New perspectives and directions in schizophrenia therapeutics: advances related to non-dopaminergic systems.
    Al-Nuaimi S; Chaves C; Hallak JE; Baker GB; Dursun S
    Braz J Psychiatry; 2010 Dec; 32(4):333-8. PubMed ID: 21308251
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine receptor downregulation: an alternative strategy for schizophrenia treatment.
    Tsai SJ
    Med Hypotheses; 2004; 63(6):1047-50. PubMed ID: 15504573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia.
    Freedman R
    N Engl J Med; 2003 Oct; 349(18):1738-49. PubMed ID: 14585943
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopamine D4 receptors: a new opportunity for research on schizophrenia.
    Liégeois J; Eyrolles L; Bruhwyler J; Delarge J
    Curr Med Chem; 1998 Apr; 5(2):77-100. PubMed ID: 9481035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The optimal level of dopaminergic neurotransmission].
    de Haan L
    Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1721-2. PubMed ID: 16114285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-dopaminergic drugs in schizophrenia].
    Llorca PM
    Encephale; 2006 Oct; 32(5 Pt 4):S913-6; discussion S917. PubMed ID: 17119505
    [No Abstract]   [Full Text] [Related]  

  • 7. The relationship between risperidone plasma levels and dopamine D2 occupancy: a positron emission tomographic study.
    Remington G; Kapur S; Zipursky R
    J Clin Psychopharmacol; 1998 Feb; 18(1):82-3. PubMed ID: 9472848
    [No Abstract]   [Full Text] [Related]  

  • 8. Clozapine treatment of schizophrenia.
    Pickar D; Hsiao JK
    JAMA; 1995 Sep; 274(12):981-3. PubMed ID: 7674530
    [No Abstract]   [Full Text] [Related]  

  • 9. Atypical neuroleptics in children and adolescents.
    Scahill L; Lynch KA
    J Child Adolesc Psychiatr Nurs; 1998; 11(1):38-43. PubMed ID: 9611543
    [No Abstract]   [Full Text] [Related]  

  • 10. British Association for Psychopharmacology--2008 Summer Meeting.
    Jenkins TA
    IDrugs; 2008 Oct; 11(10):720-3. PubMed ID: 18828070
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopaminergic mechanisms in the pathogenesis of schizophrenia.
    Goldstein M; Deutch AY
    FASEB J; 1992 Apr; 6(7):2413-21. PubMed ID: 1348713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha7 nicotinic cholinergic neuromodulation may reconcile multiple neurotransmitter hypotheses of schizophrenia.
    Bencherif M; Stachowiak MK; Kucinski AJ; Lippiello PM
    Med Hypotheses; 2012 May; 78(5):594-600. PubMed ID: 22336089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schizophrenia and L-745,870, a novel dopamine D4 receptor antagonist.
    Bristow LJ; Kramer MS; Kulagowski J; Patel S; Ragan CI; Seabrook GR
    Trends Pharmacol Sci; 1997 Jun; 18(6):186-8. PubMed ID: 9226994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ziprasidone (Geodon) for schizophrenia.
    Med Lett Drugs Ther; 2001 Jun; 43(1106):51-2. PubMed ID: 11402259
    [No Abstract]   [Full Text] [Related]  

  • 15. Schizophrenia.
    Morrison PD; Murray RM
    Curr Biol; 2005 Dec; 15(24):R980-4. PubMed ID: 16360673
    [No Abstract]   [Full Text] [Related]  

  • 16. Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.
    Nørbak-Emig H; Ebdrup BH; Fagerlund B; Svarer C; Rasmussen H; Friberg L; Allerup PN; Rostrup E; Pinborg LH; Glenthøj BY
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26819282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and novel approaches to the drug treatment of schizophrenia.
    Rowley M; Bristow LJ; Hutson PH
    J Med Chem; 2001 Feb; 44(4):477-501. PubMed ID: 11170639
    [No Abstract]   [Full Text] [Related]  

  • 18. Iloperidone for schizophrenia.
    Rado J; Janicak PG
    Expert Opin Pharmacother; 2010 Aug; 11(12):2087-93. PubMed ID: 20586713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amisulpride monotherapy in a patient with clozapine-resistant schizophrenia.
    Pehlivanidis A; Spyropoulou AC; Tourkantonis A; Papadimitriou GN
    Clin Neuropharmacol; 2010 May; 33(3):168. PubMed ID: 20502137
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopamine D2 and D4 receptor ligands: relation to antipsychotic action.
    Wilson JM; Sanyal S; Van Tol HH
    Eur J Pharmacol; 1998 Jun; 351(3):273-86. PubMed ID: 9721018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.